Clinical Trials Logo
  1. Home
  2. Pregnancy
  3. NCT04599725
  4. Details
NCT04599725 Clinical Trial

Feasibility of Telemedicine Medical Abortion

Pregnancy Clinical Trial

Official title:
TelAbortion: Medical Abortion by Direct-to-patient Telemedicine and Mail

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04599725
Other study ID # 1049
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 1, 2020
Est. completion date October 1, 2021

Study information
Verified date October 2020
Source Gynuity Health Projects
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This pilot study is designed to obtain data on the safety, acceptability, and feasibility of providing abortion by direct-to-patient telemedicine and mail.

Recruitment information / eligibility
Status Completed
Enrollment 413
Est. completion date October 1, 2021
Est. primary completion date October 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 10 Years to 50 Years
Eligibility Inclusion Criteria: - desires abortion Exclusion Criteria: - medically ineligible for procedure

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• medical abortion
medical abortion

Locations
Country Name City State
United States Planned Parenthood of the Rocky Mountains Albuquerque New Mexico
United States Carafem Atlanta Georgia
United States Maine Family Planning Augusta Maine
United States Planned Parenthood of Montana Billings Montana
United States Maine Family Planning Boston Massachusetts
United States Carafem Chevy Chase Maryland
United States Planned Parenthood of the Rocky Mountains Denver Colorado
United States The University of Hawaii Women's Options Centers Honolulu Hawaii
United States Emma Goldman Clinic Iowa City Iowa
United States Maine Family Planning New York New York
United States Planned Parenthood Columbia Willamette Portland Oregon
United States Planned Parenthood Minnesota, North Dakota, South Dakota Saint Paul Minnesota
United States Carafem Skokie Illinois
United States Planned Parenthood Columbia Willamette Vancouver Washington
United States Carafem Washington District of Columbia

Sponsors (1)
Lead Sponsor Collaborator
Gynuity Health Projects

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Number of participants with adverse events 2 years
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Terminated NCT02537145 - PregnanT Moms Measure - Do-It-Yourself Health Monitoring and Simulation of Health in Pregnant Women